Compare SMG & TVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SMG | TVTX |
|---|---|---|
| Founded | 1868 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Agricultural Chemicals | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.3B | 3.3B |
| IPO Year | N/A | N/A |
| Metric | SMG | TVTX |
|---|---|---|
| Price | $63.78 | $27.88 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 6 | 15 |
| Target Price | ★ $70.33 | $37.21 |
| AVG Volume (30 Days) | 712.5K | ★ 3.2M |
| Earning Date | 01-28-2026 | 02-19-2026 |
| Dividend Yield | ★ 4.20% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 2.47 | N/A |
| Revenue | ★ $3,413,100,000.00 | $435,826,000.00 |
| Revenue This Year | $1.34 | $120.02 |
| Revenue Next Year | $2.23 | $37.00 |
| P/E Ratio | $25.43 | ★ N/A |
| Revenue Growth | N/A | ★ 114.22 |
| 52 Week Low | $45.61 | $12.91 |
| 52 Week High | $79.12 | $42.13 |
| Indicator | SMG | TVTX |
|---|---|---|
| Relative Strength Index (RSI) | 65.48 | 29.00 |
| Support Level | $61.94 | $22.59 |
| Resistance Level | $64.60 | $29.31 |
| Average True Range (ATR) | 1.74 | 2.40 |
| MACD | 0.24 | -1.06 |
| Stochastic Oscillator | 84.72 | 29.85 |
Scotts Miracle-Gro is the largest purveyor of home lawn and gardening products in the US. The business consists of three reporting segments: US consumer, Hawthorne, and other. The US consumer segment consists of a broad range of lawncare products, including grass seed, fertilizer, and lawn-related weed, animal, and disease control. US consumer typically generates the vast majority of companywide revenue and profits. Hawthorne sells indoor gardening and hydroponic equipment, particularly to the cannabis growing industry, while the other segment primarily consists of lawn and gardening products sold in Canada. Its lawncare and gardening products are well-recognized brands in the US, including Scotts, Miracle-Gro, Roundup, Ortho, and Tomcat.
Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN)-rare kidney disorders that often cause end-stage kidney disease.